A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma

INTRODUCTION: Tumor mutation burden (TMB) is an emerging biomarker for immunotherapy of hepatocellular carcinoma (HCC), but its value for clinical application has not been fully revealed. MATERIALS AND METHODS: We used the Wilcox test to identify the differentially expressed immune-related genes (DE...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Junyu, Wu, Liqun, Zang, Yunjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691640/
https://www.ncbi.nlm.nih.gov/pubmed/33282911
http://dx.doi.org/10.3389/fmolb.2020.581354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691640/
https://www.ncbi.nlm.nih.gov/pubmed/33282911
http://dx.doi.org/10.3389/fmolb.2020.581354

Ejemplares similares